Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
periodontitis pharyngitis gingivitis amalgam fluoride mutans pulp candidiasis pulp malocclusionYour Article Summary
The oncogenic effects of constitutive Stat3 signaling in salivary gland cancer cells are mediated by survivin and modulated by the NSAID sulindac
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics, 06/19/09
Nikitakis NG et al. - Taken together, these data support the importance of the constitutive Stat3 signaling for growth and survival of salivary gland cancer cells through the induction of survivin. Inhibition of the oncogenic Stat3-survivin pathway in these cells can be achieved by selective targeting techniques or treatment with the NSAID sulindac and holds promise for the treatment of salivary gland cancer.
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Combined topical dexamethasone/tacrolimus therapy for management of oral chronic GVHD
Bone Marrow Transplantation, 11/05/09
Ketoprofen 2% Oral Gel
U.S. Pharmacist, 11/06/09
Effects of preoperative ibuprofen on pain after separator placement
American Journal of Orthodontics and Dentofacial Orthopedics, 10/29/09
Today in OMF Pathology...keeping you current
Receive free subspecialty "5-minute updates" via email
Combined topical dexamethasone/tacrolimus therapy for management of oral chronic GVHD
Bone Marrow Transplantation, 11/05/09
Mucositis: The impact, biology and therapeutic opportunities of oral mucositis
Oral Oncology , 10/21/09
Longitudinal Cohort Study of Risk Factors in Cancer Patients of Bisphosphonate-Related Osteonecrosis of the Jaw
Journal of Clinical Oncology, 10/12/09
Article Search
Sponsor


See Latest Articles


